Skip to main content
Equibles
USNA logo

USNA · Usana Health Sciences Inc · Webcasts, Transcripts & Audio

Track USNA — free

Use USNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research USNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.85 +0.03 (+0.20%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Market Cap
$267.91M
Shares
18.48M
Volume · Oct 5 163.73K Avg daily vol (3M) 183.22K

Usana Health Sciences Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Usana Health Sciences Inc (USNA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼14.7% $227.96M $12.79M '22 Q4 22-02-08 ▼9% $248.36M $18.38M '23 Q1 22-07-26 ▼9.9% $238.20M $17.29M '23 Q2 22-10-25 ▼8.5% $213.37M $11.35M '23 Q3 23-01-05 ▼3% $221.08M $16.77M '23 Q4 23-04-25 ▼8.3% $227.80M $16.54M '24 Q1 23-07-25 ▼10.6% $212.87M $10.43M '24 Q2 23-10-24 ▼3.4% $213.61M $4.45M '24 Q4 24-04-30 ▲9.5% $249.54M $9.40M '25 Q1 24-07-23 ▲10.8% $235.85M $9.65M '25 Q2 24-10-22 ▲5.9% $226.20M −$1.77M '25 Q4 25-04-22 ▲0.3% $250.22M $7.51M '26 Q1 25-07-22 LATEST ▼5.3% $223.27M −$21.38M '26 Q2 25-10-09
Earnings call
FY27 · Q2
2026-08-05
Usana Health Sciences Inc (USNA) Q2 2027 Earnings Call Transcript
Positive tone Omni-channel diversification strategy Core nutritional business performance Rise Wellness packaging issue
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY27 · Q1
2026-05-06
Usana Health Sciences Inc (USNA) Q1 2027 Earnings Call Transcript
Confident tone Rise Wellness / ProteinPop retail expansion Haya (HIA) omni-channel brand Core nutritional business stabilization
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-02-18
Usana Health Sciences Inc (USNA) Q4 2026 Earnings Call Transcript
Positive tone Rise Wellness and Haya growth Leadership transition and renewed strategic focus Fiscal 2026 sales outlook
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q2
2025-10-09
Usana Health Sciences Inc (USNA) Q2 2026 Earnings Call
Revenue
$223.27M
▼ 5.3% YoY
Diluted EPS
$-1.16
▼ 323.1% YoY
Gross margin
78.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-07-22
Usana Health Sciences Inc (USNA) Q1 2026 Earnings Call Transcript
Positive tone Rise Wellness and ProteinPop Retail expansion Core nutritional stabilization
Revenue
$250.22M
▲ 0.3% YoY
Diluted EPS
$0.41
▼ 16.3% YoY
Gross margin
76.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-04-22
Usana Health Sciences Inc (USNA) Q4 2025 Earnings Call Transcript
Positive tone Fiscal 2026 Outlook and Net Sales Growth Guidance Hiya Venture Growth Rise Wellness / Protein Pop Expansion
Revenue
$226.20M*
▲ 5.9% YoY
Gross margin
78.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q2
2024-10-22
Usana Health Sciences Inc (USNA) Q2 2025 Earnings Call Transcript
Confident tone Brand Partner Strategy & Compensation Hiya Acquisition M&A Pipeline & AI Tools
Revenue
$235.85M
▲ 10.8% YoY
Diluted EPS
$0.52
▼ 3.7% YoY
Gross margin
78.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-07-23
Usana Health Sciences Inc (USNA) Q1 2025 Earnings Call Transcript
Positive tone Tariffs and trade policy exposure Hiya acquisition and growth China market performance
Revenue
$249.54M
▲ 9.5% YoY
Diluted EPS
$0.49
▼ 43% YoY
Gross margin
79.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-04-30
Usana Health Sciences Inc (USNA) Q4 2024 Earnings Call Transcript
Positive tone Hyatt Acquisition Product Innovation and Launches Associate Incentives and Engagement
Revenue
$213.61M*
▼ 3.4% YoY
Gross margin
82.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2023-10-24
Usana Health Sciences Inc (USNA) Q2 2024 Earnings Call Transcript
Revenue
$212.87M
▼ 10.6% YoY
Diluted EPS
$0.54
▼ 39.3% YoY
Gross margin
81.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-07-25
Usana Health Sciences Inc (USNA) Q1 2024 Earnings Call Transcript
Revenue
$227.80M
▼ 8.3% YoY
Diluted EPS
$0.86
▼ 9.5% YoY
Gross margin
81.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-04-25
Usana Health Sciences Inc (USNA) Q4 2023 Earnings Call Transcript
Revenue
$221.08M*
▼ 3% YoY
Gross margin
80.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-01-05
Usana Health Sciences Inc (USNA) Q3 2023 Earnings Call Transcript
Revenue
$213.37M
▼ 8.5% YoY
Diluted EPS
$0.59
▼ 24.4% YoY
Gross margin
80.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-10-25
Usana Health Sciences Inc (USNA) Q2 2023 Earnings Call Transcript
Revenue
$238.20M
▼ 9.9% YoY
Diluted EPS
$0.89
▼ 11% YoY
Gross margin
81.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-07-26
Usana Health Sciences Inc (USNA) Q1 2023 Earnings Call Transcript
Revenue
$248.36M
▼ 9% YoY
Diluted EPS
$0.95
▼ 17.4% YoY
Gross margin
80.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-02-08
Usana Health Sciences Inc (USNA) Q4 2022 Earnings Call Transcript
Revenue
$227.96M*
▼ 14.7% YoY
Gross margin
79.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2021-10-26
Usana Health Sciences Inc (USNA) Q2 2022 Earnings Call Transcript
Revenue
$264.47M
▼ 21.5% YoY
Diluted EPS
$1.00
▼ 46.5% YoY
Gross margin
81.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-07-27
Usana Health Sciences Inc (USNA) Q1 2022 Earnings Call Transcript
Revenue
$272.87M
▼ 11.4% YoY
Diluted EPS
$1.15
▼ 20.7% YoY
Gross margin
81.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-04-27
Usana Health Sciences Inc (USNA) Q4 2021 Earnings Call Transcript
Revenue
$267.30M*
▼ 13.9% YoY
Gross margin
80.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q2
2020-10-20
Usana Health Sciences Inc (USNA) Q2 2021 Earnings Call Transcript
Revenue
$336.84M
▲ 30.1% YoY
Diluted EPS
$1.87
▲ 41.7% YoY
Gross margin
83.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-07-21
Usana Health Sciences Inc (USNA) Q1 2021 Earnings Call Transcript
Revenue
$307.98M
▲ 15.5% YoY
Diluted EPS
$1.45
▲ 17.9% YoY
Gross margin
81.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-02-04
Usana Health Sciences Inc (USNA) Q4 2020 Earnings Call Transcript
Revenue
$310.52M*
▲ 14.5% YoY
Gross margin
81.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q1
2019-04-30
Usana Health Sciences Inc (USNA) Q1 2020 Earnings Call Transcript
Revenue
$266.62M
▼ 2.3% YoY
Diluted EPS
$1.23
▲ 21.8% YoY
Gross margin
82.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 webcasts
Key facts CIK 896264 CUSIP 90328M107 13F (30d) 3 filings 3 filers Visit website Investor relations